Hossam El Benawi Shares Multi Site LVT Study from Mayo Clinic
Hossam El Benawi, Senior Clinical Research Fellow of Cardiovascular Medicine at Mayo Clinic, shared on LinkedIn:
”Mayo Clinic Multi Site LVT Study Part 1:
DOAC Vs VKA for LVT.”
A Mayo Clinic multi-site study of 182 patients with left ventricular thrombus (LVT) found that direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) had similar effectiveness in preventing stroke or embolism and achieving thrombus resolution.
However, VKAs were linked to a higher risk of major bleeding.
The risk of embolization was greatest within the first eight weeks, suggesting that an initial DOAC loading dose may help reduce early events.
Read the full article in RPTH/ScienceDirect.
Article: Comparison of direct oral anticoagulants and vitamin K antagonists in the treatment of left ventricular thrombi: a retrospective cohort study
Authors: Hossam El Benawi, Kirsten Lipps, Samuel Heller Jr., David A. Liedl, Raymond C. Shields, Ana I. Casanegra, Stanislav Henkin, Thom W. Rooke, Paul W. Wennberg, Waldemar E. Wysokinski, Robert D. McBane, Damon E. Houghton
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Oct 4, 2026, 13:56Maria Elisa Mancuso: EHC 2026 Highlights the Unmet Needs of Women with Bleeding Disorders
-
Oct 4, 2026, 13:53Nirmal Shaji George: Individualizing Anticoagulation in Complex APS and Thrombocytopenia
-
Oct 4, 2026, 13:5210 Posts Not to Miss This Week
-
Oct 4, 2026, 13:45Suswapna Singh Rawat: The Clinical Significance of Coronary Plaque Stability
-
Oct 4, 2026, 13:35Sumyea Kabir: Optimizing Plasma Selection for Therapeutic Plasma Exchange in TTP
-
Oct 4, 2026, 13:31Swati Raikwar: Microplastics as a Threat to Cerebral Blood Flow
-
Oct 4, 2026, 13:18Maria Elisa Mancuso: EHC 2026 Opens with Focus on Haemophilia Care, Access and Rare Disorders
-
Oct 4, 2026, 13:16Anita Brikman: Inside the Plasma Donation Journey
-
Oct 4, 2026, 13:13Overcoming FVIII Inhibitors With Efanesoctocog Alfa – JTH